#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Tachycardia-induced cardiomyopathy


Authors: K. Linhartová;  L. Riedlbauchová
Authors‘ workplace: Kardiologická klinika 2. LF UK a FN Motol, Praha
Published in: Kardiol Rev Int Med 2011, 13(4): 225-227

Overview

Tachycardia-induced cardiomyopathy appears to be a  possibly not very rare clinical event, characterised by a reversible disorder of the systolic function of the ventricles with signs of cardiac failure based on chronic or even intermittent tachyarrythmia. In the therapeutic approach, a key role is played, alongside the treatment of cardiac failure, by the normalisation, or at least adequate control of cardiac rhythm, preferably by non-pharmacological treatment, which leads to restoration of the systolic function of the ventricles, generally within weeks.

Keywords:
cardiomyopathy – supraventricular tachyarrhythmias – radiofrequential ablation


Sources

1. Riedlbauchová L. Kardiomyopatie indukovaná tachykardií. In: Veselka J, Linhartová K, Zemánek D et al (eds). Kardiomyopatie. Praha: Galén 2009: 139–143.

2. Umana E, Solares CA, Alpert MA. Tachycardia-induced cardiomyopathy. Review. Am J Med 2003; 114: 51–55.

3. Shinbane JS, Wood MA, Jensen DN et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 1997; 29: 709–715.

4. Lishmanov A, Chockalingam P, Senthilkumar A et al. Tachycardia-Induced Cardiomyopathy: Evaluation and Therapeutic Options. Congest Heart Fail 2010; 16: 122–126.

5. Khasnis A, Jongnarangsin K, Abela G et al. Tachycardia-induced cardiomyopathy: a review of literature. Pacing Clin Electrophysiol 2005; 28: 710–721.

Labels
Paediatric cardiology Internal medicine Cardiac surgery Cardiology
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#